Human epithelial cells will be cultured and we will attempt to control their state of differentiation by agents such as calcium, growth factors, and tumor promoting agents in order to provide targets for HPV transformation. As calcium phosphate precipitation of DNA onto the cells may not be the ideal means of introduction, other approaches such as DEAE dextran, protoplast fusion, microinjection and electroporation will be tried. The transformation protocols will include in addition to HPV DNA exposure of the cells to tumor promoting agents, other oncogenes, eg Ha-ras, growth factors, and the HSV transforming fragment. Co-transformation protocols will be used with a dominant selectable marker, eg. neomycin or gpt to select cells which have retained HPV DNA. Another approach will be to link the coding regions of potential transforming regions such as E2 and E5 to strong promoter and enhancer sequences to ask whether, if these genes are efficiently expressed, they can transform cells. We will analyze the activated genes in tumor cells and benign neoplasms which contain various HPV types. DNAs from these tissues will be used to transform NIH3T3 cells and mouse epithelial cells. The transformants will be analyzed for the retention of human and viral sequences. Secondary and tertiary transformants will be obtained and lambda libraries will be constructed to identify the oncogenes transferred in this way. The tumors and other HPV containing tissues will be analyzed for rearrangements, amplification or altered expression of known cellular oncogenes.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA042792-01A1
Application #
3939032
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Bao, Xiao; Hanson, Aimee L; Madeleine, Margaret M et al. (2018) HLA and KIR Associations of Cervical Neoplasia. J Infect Dis 218:2006-2015
Leo, Paul J; Madeleine, Margaret M; Wang, Sophia et al. (2017) Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study. PLoS Genet 13:e1006866
Wallace, Nicholas A; Khanal, Sujita; Robinson, Kristin L et al. (2017) High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway. J Virol 91:
Madeleine, Margaret M; Johnson, Lisa G; Doody, David R et al. (2016) Natural Antibodies to Human Papillomavirus 16 and Recurrence of Vulvar High-Grade Intraepithelial Neoplasia (VIN3). J Low Genit Tract Dis 20:257-60
Hardikar, Sheetal; Johnson, Lisa G; Malkki, Mari et al. (2015) A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers. Gynecol Oncol 139:90-6
Wallace, Nicholas A; Robinson, Kristin; Howie, Heather L et al. (2015) ?-HPV 5 and 8 E6 disrupt homology dependent double strand break repair by attenuating BRCA1 and BRCA2 expression and foci formation. PLoS Pathog 11:e1004687
Galloway, Denise A; Laimins, Laimonis A (2015) Human papillomaviruses: shared and distinct pathways for pathogenesis. Curr Opin Virol 14:87-92
Safaeian, Mahboobeh; Johnson, Lisa G; Yu, Kai et al. (2014) Human Leukocyte Antigen Class I and II Alleles and Cervical Adenocarcinoma. Front Oncol 4:119
Madeleine, Margaret M; Carter, Joseph J; Johnson, Lisa G et al. (2014) Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants. Cancer Med 3:1440-7
Wallace, Nicholas A; Galloway, Denise A (2014) Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses. Semin Cancer Biol 26:30-42

Showing the most recent 10 out of 127 publications